Combination Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma-Reply

Michael J Wagner^{1

2}, Lee D Cranmer^{1

2}, Seth M Pollack^{1

2}

Affiliations

¹ Division of Oncology, Department of Medicine, University of Washington, Seattle.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Comment

Michael J Wagner et al. JAMA Oncol. 2021.

. 2021 Mar 1;7(3):465-466.

doi: 10.1001/jamaoncol.2020.7873.

Michael J Wagner^{1

2}, Lee D Cranmer^{1

2}, Seth M Pollack^{1

2}

¹ Division of Oncology, Department of Medicine, University of Washington, Seattle.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

No abstract available

Comment on

Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical Trial.
Pollack SM, Redman MW, Baker KK, Wagner MJ, Schroeder BA, Loggers ET, Trieselmann K, Copeland VC, Zhang S, Black G, McDonnell S, Gregory J, Johnson R, Moore R, Jones RL, Cranmer LD. Pollack SM, et al. JAMA Oncol. 2020 Nov 1;6(11):1778-1782. doi: 10.1001/jamaoncol.2020.3689. JAMA Oncol. 2020. PMID: 32910151 Free PMC article. Clinical Trial.
Combination Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma.
Baa AK, Rastogi S. Baa AK, et al. JAMA Oncol. 2021 Mar 1;7(3):465. doi: 10.1001/jamaoncol.2020.7868. JAMA Oncol. 2021. PMID: 33507225 No abstract available.